21-Jan-2021 | Zion Market Research
According to Zion Market Research, the global proteinase K market is slated to expand at a CAGR of 7.5% during the forecast period 2020–2026 and accrue revenue worth USD 15.7 Billion by 2026. The growth of the proteinase K market during the assessment period can be credited to massive use of the enzyme in in-vitro clinical trials due to the ability of the enzyme in eradicating endotoxins. Reportedly, detection of COVID-19 in patients through treating of their samples with Proteinase K has proved to be a success in absence of RNA extraction. According to the clinical outcomes, the use of the enzyme proved to be an effective method for diagnosing COVID-19 with over 90% of samples tested through the Proteinase K matching with results derived through the standard methods of testing for COVID-19. All these aforementioned factors will enlarge the scope of the proteinase K market over the assessment period.
Infectious Diseases Segment To Dominate Therapeutic Area Landscape Over 2020-2026
The dominance of the segment over the assessment timeframe can be credited to massive use of proteinase K enzyme in diagnosing contagious ailments. For the record, proteinase K has assisted in effectively treating a large number of contagious diseases. Moreover, the enzyme has aided in effective DNA incubation & extraction from hepatitis B.
Powder Form Of Proteinase K To Make Notable Contributions Towards Overall Market Size By 2026
The powder form of the enzyme is anticipated to account majorly towards the growth of proteinase K market over 2020-2026 owing to its elongated shelf life as compared to liquid form. Furthermore, the powder form allows stock-based services according to standard protocols, thereby further contributing towards the overall market size.
North America To Make Noteworthy Contributions Towards Market Share During Forecast Period
The growth of the regional market over the projected timeframe can be credited to rise in the incidences of cancer in the countries such as the U.S. and Canada. As per American Cancer Society, in 2018 nearly seventeen lakh cancer cases were diagnosed and six lakhs died due to cancer in the U.S. Massive use of NGS and PCR techniques using Proteinase K for diagnosing cancer in the clinics will further prompt the regional market growth.
Key participants profiled in the report are Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen, Amano Enzyme Inc., Affymetrix, BBI Solutions, Dyadic International, Codexis, Inc., F. Hoffmann-La Roche Ltd., Biocatalysts Ltd., and Merck KGaA.
Browse the full “Proteinase K Market - By Form (Powder And Liquid), By Therapeutic Area (Neurology, Nephrology, Diabetes, Oncology, Contagious Diseases, Autoimmune Disease, And Cardiology), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2020 – 2026.” Report at https://www.zionmarketresearch.com/report/proteinase-k-market
The global Proteinase K Market is segmented as follows:
By Therapeutic Area:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651